Nolan Sigal
Private Equity Investor bei Alerce Investment Management LP
Vermögen: - $ am 30.04.2024
Profil
Nolan H.
Sigal was the founder of Tunitas Therapeutics, Inc. (founded in 2007) where he held the titles of President, Chief Executive Officer & Director from 2007 to 2017.
He is currently a Partner at Alerce Investment Management LP since 2017.
Dr. Sigal's former positions include being an Executive Director-Immunology Research at Merck & Co., Inc. from 1983 to 1993, a Director at Clearant, Inc., an Independent Director at Aileron Therapeutics, Inc. from 2019 to 2024, a Senior Vice President at Pharmacopeia LLC from 1993 to 1999, a CSO, EVP-Research & Development at Cytokinetics, Inc., and the President of Trellis Bioscience, Inc. from 2004 to 2007.
He also served as an Assistant Professor at the University of Toronto from 1980 to 1984 and as a Senior Vice President-Research at Pharmacopeia, Inc.Dr. Sigal obtained his undergraduate degree from Princeton University in 1971 and his doctorate degree from the University of Pennsylvania Medical Center in 1977.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.11.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Nolan Sigal
| Unternehmen | Position | Beginn |
|---|---|---|
Alerce Investment Management LP
 Alerce Investment Management LP Investment ManagersFinance Alerce Investment Management LP (Alerce Investment) is a venture capital subsidiary of Satter Investment Management LLC founded by Muneer Satter. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01.12.2017 |
Ehemalige bekannte Positionen von Nolan Sigal
| Unternehmen | Position | Ende |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 29.02.2024 |
Tunitas Therapeutics, Inc.
 Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Gründer | 01.12.2017 |
Clearant, Inc.
 Clearant, Inc. Pharmaceuticals: MajorHealth Technology Clearant, Inc. produces tissue allograft implants, plasma therapies, blood and recombinant products. The company was founded on April 30, 1999 and is headquartered in Orlando, FL. | Direktor/Vorstandsmitglied | 25.04.2007 |
Trellis Bioscience, Inc.
 Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Präsident | 01.01.2007 |
Pharmacopeia LLC
 Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01.10.1999 |
Ausbildung von Nolan Sigal
| Princeton University | Undergraduate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| MERCK & CO., INC. | Health Technology |
| AILERON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Trellis Bioscience, Inc.
Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Clearant, Inc.
Clearant, Inc. Pharmaceuticals: MajorHealth Technology Clearant, Inc. produces tissue allograft implants, plasma therapies, blood and recombinant products. The company was founded on April 30, 1999 and is headquartered in Orlando, FL. | Health Technology |
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Alerce Investment Management LP
Alerce Investment Management LP Investment ManagersFinance Alerce Investment Management LP (Alerce Investment) is a venture capital subsidiary of Satter Investment Management LLC founded by Muneer Satter. The firm is headquartered in Chicago, Illinois. | Finance |
| Pharmacopeia, Inc. /Old/ | Commercial Services |
